Format

Send to

Choose Destination
Clin Chest Med. 2013 Jun;34(2):283-92. doi: 10.1016/j.ccm.2013.01.009. Epub 2013 Apr 8.

Human immunodeficiency virus-associated pulmonary arterial hypertension.

Author information

1
Division of Cardiology, San Francisco General Hospital, University of California, San Francisco, San Francisco, CA 94110, USA.

Abstract

Antiretroviral therapy has greatly increased longevity for individuals with human immunodeficiency virus (HIV) infection. About 0.5% of patients with HIV infection develop moderate to severe pulmonary arterial hypertension, which is several thousand times higher than the incidence of idiopathic pulmonary arterial hypertension. As more than 30 million individuals are chronically infected, HIV infection could soon become one of the most common causes of pulmonary arterial hypertension worldwide. Pulmonary arterial hypertension is a relentlessly progressive disease leading to right heart failure and death. In this article the available data on epidemiology, hemodynamics, mechanisms, and therapeutic strategies for HIV-associated pulmonary arterial hypertension are reviewed.

PMID:
23702177
PMCID:
PMC3749917
DOI:
10.1016/j.ccm.2013.01.009
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center